Literature DB >> 2868492

Early treatment events and prediction of response to neuroleptics in schizophrenia.

A G Awad, T P Hogan.   

Abstract

Events that occur early in the course of neuroleptic drug therapy in schizophrenia and which may be useful in predicting clinical outcome were investigated. Early subjective response and symptom change at twenty-four and forty-eight hours following initiation of drug therapy with either CPZ or haloperidol were the only variables that significantly related to therapeutic outcome. These preliminary results replicate and confirm previous results and provide a tool which can be included with other available approaches in developing a battery for prediction of drug response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2868492     DOI: 10.1016/0278-5846(85)90021-1

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

Review 1.  Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.

Authors:  A George Awad
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

2.  A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation.

Authors:  A G Awad; L N Voruganti; R J Heslegrave
Journal:  Qual Life Res       Date:  1997-01       Impact factor: 4.147

Review 3.  Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Revisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior.

Authors:  A George Awad; Lakshmi L N P Voruganti
Journal:  Ther Adv Psychopharmacol       Date:  2015-06

Review 5.  The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 6.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

7.  Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).

Authors:  I García-Cabeza; J C Gómez; J A Sacristán; E Edgell; M González de Chavez
Journal:  BMC Psychiatry       Date:  2001-12-28       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.